GSA Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$17.7M |
| 2 |
Starbucks
SBUX
|
+$16.5M |
| 3 |
Williams Companies
WMB
|
+$15.6M |
| 4 |
Herc Holdings
HRI
|
+$14.9M |
| 5 |
Delta Air Lines
DAL
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$24.9M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$15.2M |
| 3 |
TJX Companies
TJX
|
+$14.9M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$14.4M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$14.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.76% |
| 2 | Consumer Discretionary | 13.95% |
| 3 | Industrials | 12.6% |
| 4 | Technology | 11% |
| 5 | Energy | 9.44% |
Similar funds
GSA Capital Partners's Q3 2014 Portfolio in Review
As of Q3 2014, GSA Capital Partners held 2,190 positions worth $1.9B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
GSA Capital Partners withdrew a net $202M in Q3 2014, closing 510 positions and reducing 646 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $15.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, GSA Capital Partners opened a new position in Illumina worth $16.9M.
- GSA Capital Partners's largest Q3 2014 buy was Illumina: 105,983 shares worth $16.9M.
- GSA Capital Partners added most to Williams Companies in Q3 2014, an estimated $15.6M increase.
- GSA Capital Partners's biggest Q3 2014 reduction was Marathon Petroleum, cutting an estimated $24.9M.
- GSA Capital Partners fully exited Regeneron Pharmaceuticals in Q3 2014, selling an estimated $15.2M.
- GSA Capital Partners's ten largest holdings make up 7.7% of its $1.9B portfolio in Q3 2014.
- GSA Capital Partners opened 419 new positions and closed 510 in Q3 2014.
- GSA Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.9B.
Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.